vs

Side-by-side financial comparison of Snowflake Inc. (SNOW) and Steris (STE). Click either name above to swap in a different company.

Steris is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.2× Snowflake Inc.). Steris runs the higher net margin — 12.9% vs -24.2%, a 37.1% gap on every dollar of revenue. On growth, Snowflake Inc. posted the faster year-over-year revenue change (28.7% vs 9.2%). Steris produced more free cash flow last quarter ($199.5M vs $113.6M). Over the past eight quarters, Snowflake Inc.'s revenue compounded faster (25.1% CAGR vs 15.8%).

Snowflake Inc. is an American cloud-based data platform company founded in San Mateo, California, and headquartered in Bozeman, Montana. It operates a platform that supports data analysis and simultaneous access to data sets with minimal latency. It operates on Amazon Web Services, Microsoft Azure, and Google Cloud Platform.

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.

SNOW vs STE — Head-to-Head

Bigger by revenue
STE
STE
1.2× larger
STE
$1.5B
$1.2B
SNOW
Growing faster (revenue YoY)
SNOW
SNOW
+19.6% gap
SNOW
28.7%
9.2%
STE
Higher net margin
STE
STE
37.1% more per $
STE
12.9%
-24.2%
SNOW
More free cash flow
STE
STE
$85.9M more FCF
STE
$199.5M
$113.6M
SNOW
Faster 2-yr revenue CAGR
SNOW
SNOW
Annualised
SNOW
25.1%
15.8%
STE

Income Statement — Q3 FY2026 vs Q3 FY2026

Metric
SNOW
SNOW
STE
STE
Revenue
$1.2B
$1.5B
Net Profit
$-294.0M
$192.9M
Gross Margin
67.8%
43.8%
Operating Margin
-27.2%
18.3%
Net Margin
-24.2%
12.9%
Revenue YoY
28.7%
9.2%
Net Profit YoY
9.4%
11.2%
EPS (diluted)
$-0.87
$1.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SNOW
SNOW
STE
STE
Q4 25
$1.2B
$1.5B
Q3 25
$1.1B
$1.5B
Q2 25
$1.0B
$1.4B
Q1 25
$986.8M
$1.5B
Q4 24
$942.1M
$1.4B
Q3 24
$868.8M
$1.3B
Q2 24
$828.7M
$1.3B
Q1 24
$774.7M
$1.1B
Net Profit
SNOW
SNOW
STE
STE
Q4 25
$-294.0M
$192.9M
Q3 25
$-298.0M
$191.9M
Q2 25
$-430.1M
$177.4M
Q1 25
$-327.5M
$145.7M
Q4 24
$-324.3M
$173.5M
Q3 24
$-316.9M
$150.0M
Q2 24
$-317.0M
$145.4M
Q1 24
$-169.4M
$-1.4M
Gross Margin
SNOW
SNOW
STE
STE
Q4 25
67.8%
43.8%
Q3 25
67.5%
44.2%
Q2 25
66.5%
45.1%
Q1 25
66.2%
43.3%
Q4 24
65.9%
44.5%
Q3 24
66.8%
43.6%
Q2 24
67.1%
44.7%
Q1 24
68.8%
40.2%
Operating Margin
SNOW
SNOW
STE
STE
Q4 25
-27.2%
18.3%
Q3 25
-29.7%
18.2%
Q2 25
-42.9%
17.7%
Q1 25
-39.2%
14.6%
Q4 24
-38.8%
17.9%
Q3 24
-40.9%
16.5%
Q2 24
-42.1%
14.5%
Q1 24
-35.6%
22.0%
Net Margin
SNOW
SNOW
STE
STE
Q4 25
-24.2%
12.9%
Q3 25
-26.0%
13.1%
Q2 25
-41.3%
12.8%
Q1 25
-33.2%
9.8%
Q4 24
-34.4%
12.7%
Q3 24
-36.5%
11.3%
Q2 24
-38.3%
11.4%
Q1 24
-21.9%
-0.1%
EPS (diluted)
SNOW
SNOW
STE
STE
Q4 25
$-0.87
$1.96
Q3 25
$-0.89
$1.94
Q2 25
$-1.29
$1.79
Q1 25
$-0.98
$1.48
Q4 24
$-0.98
$1.75
Q3 24
$-0.95
$1.51
Q2 24
$-0.95
$1.46
Q1 24
$-0.51
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SNOW
SNOW
STE
STE
Cash + ST InvestmentsLiquidity on hand
$1.9B
$423.7M
Total DebtLower is stronger
$1.9B
Stockholders' EquityBook value
$2.1B
$7.2B
Total Assets
$8.2B
$10.6B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SNOW
SNOW
STE
STE
Q4 25
$1.9B
$423.7M
Q3 25
$1.9B
$319.2M
Q2 25
$2.2B
$279.7M
Q1 25
$2.6B
$171.7M
Q4 24
$2.1B
$155.2M
Q3 24
$1.3B
$172.2M
Q2 24
$1.3B
$198.3M
Q1 24
$1.8B
$207.0M
Total Debt
SNOW
SNOW
STE
STE
Q4 25
$1.9B
Q3 25
$1.9B
Q2 25
$1.9B
Q1 25
$1.9B
Q4 24
$2.0B
Q3 24
$2.2B
Q2 24
$2.2B
Q1 24
$3.1B
Stockholders' Equity
SNOW
SNOW
STE
STE
Q4 25
$2.1B
$7.2B
Q3 25
$2.4B
$7.0B
Q2 25
$2.4B
$7.0B
Q1 25
$3.0B
$6.6B
Q4 24
$2.9B
$6.4B
Q3 24
$4.1B
$6.6B
Q2 24
$4.6B
$6.4B
Q1 24
$5.2B
$6.3B
Total Assets
SNOW
SNOW
STE
STE
Q4 25
$8.2B
$10.6B
Q3 25
$8.2B
$10.4B
Q2 25
$8.2B
$10.4B
Q1 25
$9.0B
$10.1B
Q4 24
$8.2B
$10.0B
Q3 24
$6.9B
$10.2B
Q2 24
$7.3B
$10.1B
Q1 24
$8.2B
$11.1B
Debt / Equity
SNOW
SNOW
STE
STE
Q4 25
0.27×
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.29×
Q4 24
0.32×
Q3 24
0.33×
Q2 24
0.35×
Q1 24
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SNOW
SNOW
STE
STE
Operating Cash FlowLast quarter
$137.5M
$298.2M
Free Cash FlowOCF − Capex
$113.6M
$199.5M
FCF MarginFCF / Revenue
9.4%
13.3%
Capex IntensityCapex / Revenue
2.0%
6.6%
Cash ConversionOCF / Net Profit
1.55×
TTM Free Cash FlowTrailing 4 quarters
$776.7M
$917.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SNOW
SNOW
STE
STE
Q4 25
$137.5M
$298.2M
Q3 25
$74.9M
$287.8M
Q2 25
$228.4M
$420.0M
Q1 25
$432.7M
$260.8M
Q4 24
$101.7M
$332.8M
Q3 24
$69.9M
$250.7M
Q2 24
$355.5M
$303.7M
Q1 24
$344.6M
$254.8M
Free Cash Flow
SNOW
SNOW
STE
STE
Q4 25
$113.6M
$199.5M
Q3 25
$58.2M
$201.3M
Q2 25
$183.4M
$326.4M
Q1 25
$421.4M
$189.9M
Q4 24
$88.3M
$243.6M
Q3 24
$64.8M
$148.8M
Q2 24
$338.9M
$195.7M
Q1 24
$331.5M
$163.3M
FCF Margin
SNOW
SNOW
STE
STE
Q4 25
9.4%
13.3%
Q3 25
5.1%
13.8%
Q2 25
17.6%
23.5%
Q1 25
42.7%
12.8%
Q4 24
9.4%
17.8%
Q3 24
7.5%
11.2%
Q2 24
40.9%
15.3%
Q1 24
42.8%
14.6%
Capex Intensity
SNOW
SNOW
STE
STE
Q4 25
2.0%
6.6%
Q3 25
1.5%
5.9%
Q2 25
4.3%
6.7%
Q1 25
1.1%
4.8%
Q4 24
1.4%
6.5%
Q3 24
0.6%
7.7%
Q2 24
2.0%
8.4%
Q1 24
1.7%
8.2%
Cash Conversion
SNOW
SNOW
STE
STE
Q4 25
1.55×
Q3 25
1.50×
Q2 25
2.37×
Q1 25
1.79×
Q4 24
1.92×
Q3 24
1.67×
Q2 24
2.09×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SNOW
SNOW

Products$1.2B96%
Professional Services And Other$54.5M4%
Related Party$6.7M1%

STE
STE

Servicerevenues$404.7M27%
Consumablerevenues$387.1M26%
Applied Sterilization Technologies$286.6M19%
Capitalequipmentrevenues$272.1M18%
Life Science$145.8M10%

Related Comparisons